
Time-dependent changes in mortality and transformation risk in MDS
2016; Elsevier BV; Volume: 128; Issue: 7 Linguagem: Inglês
10.1182/blood-2016-02-700054
ISSN1528-0020
AutoresMichael Pfeilstöcker, Heinz Tuechler, Guillermo Sanz, Julie Schanz, Guillermo Garcia‐Manero, Françesc Solé, John M. Bennett, David Bowen, Pierre Fenaux, François Dreyfus, Hagop M. Kantarjian, Andrea Kuendgen, Luca Malcovati, Mario Cazzola, Jaroslav Čermák, Christa Fonatsch, Michelle M. Le Beau, Marilyn L. Slovak, Alessandro Levis, Michael Luebbert, Jaroslaw P. Maciejewski, Sigrid Machherndl‐Spandl, Silvia M. M. Magalhães, Yasushi Miyazaki, Mikkael A. Sekeres, Wolfgang R. Sperr, Reinhard Stauder, Sudhir Tauro, Peter Valent, Teresa Vallespı́, Arjan A. van de Loosdrecht, Ulrich Germing, Detlef Haase, Peter L. Greenberg,
Tópico(s)Chronic Myeloid Leukemia Treatments
ResumoKey Points Hazards regarding mortality and leukemic transformation in MDS diminish over time in higher-risk but remain stable in lower-risk patients. This change of hazard indicates time-dependent attenuation of power of basal risk scores, which is relevant for clinical decision making.
Referência(s)